NCT04068597 2025-12-18
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
CellCentric Ltd.
Phase 1/2 Recruiting
CellCentric Ltd.
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Sumitomo Pharma America, Inc.
Peking University